Rasmus Leistner
Overview
Explore the profile of Rasmus Leistner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reyle R, Schwab F, Saydan S, Behnke M, Leistner R, Gastmeier P, et al.
Antimicrob Resist Infect Control
. 2025 Feb;
14(1):17.
PMID: 40001254
Background/introduction: Antipseudomonal antibiotics are frequently used in patients admitted to hospitals. Many of these substances are classified as a reserve or watch status by the WHO. Inappropriate risk assessment of...
2.
Hering C, Leistner R, Aghdassi S, Lemke E, Gastmeier P, Geffers C, et al.
Am J Infect Control
. 2025 Feb;
PMID: 39986354
Background: Multidrug-resistant organisms pose a significant challenge in intensive care units (ICUs). Despite contact precautions (CP) being recommended as an infection prevention measure, little is known about the burden of...
3.
Denkel L, Voss A, Caselli E, Dancer S, Leistner R, Gastmeier P, et al.
Antimicrob Resist Infect Control
. 2024 Oct;
13(1):119.
PMID: 39380032
Background: The environment of healthcare institutions plays a major role in the transmission of multidrug resistant organisms (MDRO) and likely in subsequent healthcare-associated infections (HAIs). Probiotic cleaning products are a...
4.
Hackmann C, Genath A, Gruhl D, Weber A, Maechler F, Kola A, et al.
Euro Surveill
. 2024 Sep;
29(39).
PMID: 39328155
BackgroundCarriage of multidrug-resistant organisms (MDROs) in humans constitutes an important public health concern. Cross-transmission of bacteria between animals and humans has been demonstrated before.AimOur aim was to quantify the risk...
5.
Genath A, Hackmann C, Denkel L, Weber A, Maechler F, Kola A, et al.
Antimicrob Resist Infect Control
. 2024 Sep;
13(1):107.
PMID: 39304920
Introduction: The global increase of multidrug-resistant organisms (MDROs) is one of the most urgent public health threats affecting both humans and animals. The One Health concept emphasizes the interconnectedness of...
6.
Feuer L, Frenzer S, Merle R, Leistner R, Baumer W, Bethe A, et al.
J Antimicrob Chemother
. 2024 Jul;
79(9):2273-2280.
PMID: 39007221
Background: MRSA is a major contributor to AMR-related deaths. The WHO's global action plan emphasizes a One Health approach, acknowledging the connection between humans and their companion animals. It is...
7.
Lang A, Hohmuth N, Viskovic V, Konigorski S, Scholz S, Balzer F, et al.
J Med Internet Res
. 2024 Jun;
26:e47070.
PMID: 38833299
Background: The COVID-19 pandemic posed significant challenges to global health systems. Efficient public health responses required a rapid and secure collection of health data to improve the understanding of SARS-CoV-2...
8.
Rolff J, Bonhoeffer S, Kloft C, Leistner R, Regoes R, Hochberg M
Trends Microbiol
. 2024 Jan;
32(8):736-745.
PMID: 38238231
Antimicrobial resistance (AMR) is a major global health issue. Current measures for tackling it comprise mainly the prudent use of drugs, the development of new drugs, and rapid diagnostics. Relatively...
9.
Jhelum H, cerina D, Harbort C, Lindner A, Hanitsch L, Leistner R, et al.
J Leukoc Biol
. 2023 Nov;
115(2):222-234.
PMID: 37943843
Staphylococcus aureus strains that produce the toxin Panton-Valentine leukocidin (PVL-SA) frequently cause recurrent skin and soft tissue infections. PVL binds to and kills human neutrophils, resulting in the formation of...
10.